Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) is expected to post its Q1 2025 quarterly earnings results after the market closes on Wednesday, May 14th. Analysts expect the company to announce earnings of $0.52 per share and revenue of $45.08 million for the quarter.
Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last issued its quarterly earnings results on Wednesday, February 19th. The company reported $0.55 EPS for the quarter, missing the consensus estimate of $0.56 by ($0.01). The company had revenue of $46.40 million for the quarter, compared to analyst estimates of $47.27 million. Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%.
Crescent Capital BDC Stock Up 0.4 %
NASDAQ:CCAP opened at $15.81 on Wednesday. Crescent Capital BDC has a twelve month low of $13.54 and a twelve month high of $20.19. The firm has a market capitalization of $585.95 million, a price-to-earnings ratio of 7.94 and a beta of 0.63. The company has a quick ratio of 1.26, a current ratio of 1.32 and a debt-to-equity ratio of 1.18. The stock's 50 day moving average price is $16.42 and its two-hundred day moving average price is $18.20.
Crescent Capital BDC Announces Dividend
The company also recently announced a dividend, which will be paid on Friday, June 13th. Investors of record on Friday, May 30th will be paid a $0.05 dividend. The ex-dividend date of this dividend is Friday, May 30th. Crescent Capital BDC's dividend payout ratio is presently 84.42%.
Wall Street Analyst Weigh In
A number of research analysts have recently commented on CCAP shares. Wells Fargo & Company decreased their price objective on shares of Crescent Capital BDC from $18.00 to $16.00 and set an "equal weight" rating for the company in a research report on Monday, April 28th. Keefe, Bruyette & Woods lowered their price target on Crescent Capital BDC from $20.00 to $18.50 and set an "outperform" rating on the stock in a research report on Tuesday, April 8th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $18.50.
Get Our Latest Analysis on Crescent Capital BDC
About Crescent Capital BDC
(
Get Free Report)
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Crescent Capital BDC, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.
While Crescent Capital BDC currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
